FABP2 and irritable bowel syndrome: The circulating levels of I-FABP were significantly (p < 0.0001) different among the four groups, and both D-IBS(+) and CD patients showed significantly (p < 0.01) higher levels than D-IBS(−) and HC subjects (Fig. 6B).